Evaluating the Efficacy of AI-Guided (GenAIS TM) vs. Standard Physician-Guided Dietary Supplement Prescriptions for Lowering LDL Cholesterol in Hypercholesterolemic Patients

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

May 15, 2024

Study Completion Date

June 3, 2024

Conditions
Hypercholesterolemia
Interventions
OTHER

Standart supplementation therapy group

Participants receive supplement prescriptions from a physician based on current standard practices, which include biochemical markers, genetic data, and metabolic profiles

OTHER

AI-guided supplementation therapy group

Participants receive DS prescriptions determined by an AI system, which considers genetic data, metabolic profiles, biochemical markers, and patient history.

Trial Locations (1)

630090

Center of New Medical Technologies, Novosibirsk

Sponsors
All Listed Sponsors
collaborator

Center of New Medical Technologies

OTHER

lead

S.LAB (SOLOWAYS)

OTHER

NCT06448234 - Evaluating the Efficacy of AI-Guided (GenAIS TM) vs. Standard Physician-Guided Dietary Supplement Prescriptions for Lowering LDL Cholesterol in Hypercholesterolemic Patients | Biotech Hunter | Biotech Hunter